Market Place
Sourcing Support
Strides Continues to Deliver Exceptional Highest Ever Q3FY26
30 Jan 2026 //
PRESS RELEASE
Strides Names Yajuvendra Singh M R VP Of Digital Transformation
04 Jan 2026 //
INDPHARMAPOST
Movement in Senior Management Personnel
03 Dec 2025 //
PRESS RELEASE
Strides Partners with Kenox to Expand Nasal Spray Portfolio in US
09 Sep 2025 //
PRESS RELEASE
Strides Pharma Science Report Q1 Fy26 Pat at Rs. 105.6 Cr
05 Aug 2025 //
INDPHARMAPOST
Strides Delivers a Strong Q1FY26 with ?11,197m Revenue
29 Jul 2025 //
PRESS RELEASE
Intimation pursuant to Regulation 31A
27 Jun 2025 //
PRESS RELEASE
Closure of Trading Window
27 Jun 2025 //
PRESS RELEASE
Divestment of a Dormant Step-down Wholly Owned Subsidiary
16 Jun 2025 //
PRESS RELEASE
Change in Senior Management Personnel
30 May 2025 //
PRESS RELEASE
Annual Secretarial Compliance Report for the year ended March 31
27 May 2025 //
PRESS RELEASE
Strides Pharma Q4 net profit rises 5x to Rs. 113 Cr
24 May 2025 //
PRESS RELEASE
Strides Incorporation of Step-down Wholly Owned Subsidiary in India
11 Apr 2025 //
PRESS RELEASE
Update on redemption of NCDs
03 Apr 2025 //
PRESS RELEASE
Strides Pharma Proposed de merger of Business of Arco Lab
19 Mar 2025 //
MARKET NEWS
Strides Pharma Dissolution of Generic Partners, UK
18 Mar 2025 //
MEDICAL DIALOUGE
Strides Pharma global to acquire 100% stake in Amextel
18 Mar 2025 //
BUSINESS STD
Strides Recognized Among Leading Global ESG Performers
05 Feb 2025 //
PRESS RELEASE
Strides reports 14.6% growth in Q3 FY25 revenue
31 Jan 2025 //
BSE INDIA
Strides Pharma jumps after OneSource set to debut on Jan 24
23 Jan 2025 //
PRESS RELEASE
Strides Pharma Scores 76/100 ESG Rating In S&P Global CSA 2024
22 Jan 2025 //
PRESS RELEASE
Strides Pharma Science Ltd leads gainers in `A` group
01 Jan 2025 //
BUSINESS STD
Strides Pharma Science Ltd leads losers in `A` group
04 Dec 2024 //
BUSINESS STD
Successful completion of fund raising of USD 95 Mn by Onesource
25 Nov 2024 //
EXPRESS PHARMA
OneSource Pharma Raises Rs 801 Cr via Equity Issuance
25 Nov 2024 //
BUSINESS STD
Strides Pharma rises 4% after NCLT nods creation of OneSource
21 Nov 2024 //
BUSINESS STD
Strides Pharma jumps on securing NCLT nod for OneSource
21 Nov 2024 //
BUSINESS STD
NCLT Approval for creation OneSource India’s 1st Specialty CDMO
19 Nov 2024 //
MONEY CONTROL
Strides Pharma Reports Q2 FY25 Consolidated PAT of Rs. 93.23 Cr
28 Oct 2024 //
INDIANPHARMAPOST
Strides Pharma reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr
24 Oct 2024 //
BUSINESS STD
OneSource receives equity of Rs 8,010 Mn at a pre-money equity
18 Oct 2024 //
PRESS RELEASE
OneSource unveils new brand identity at CPHI Milan
10 Oct 2024 //
INDPHARMAPOST
OneSource in talks to raise Rs 1,670 crore in pre-listing round
26 Sep 2024 //
ECONOMICTIMES
Strides secures shareholders` nod for OneSource specialty CDMO unit
11 Sep 2024 //
ECONOMICTIMES
Proxy advisors vote against Strides Pharma’s consolidation scheme
09 Sep 2024 //
ECONOMICTIMES
Strides Pharma posts Q1 FY25 PAT at Rs. 68.3 Cr
01 Aug 2024 //
PRESS RELEASE
Strides receives USFDA approval for Sevelamer Carbonate Tablets
10 May 2024 //
EXPRESS PHARMA
Strides Pharma gets USFDA nod for antidepressant medication
09 Apr 2024 //
FIRSTWORLD PHARMA
Strides receives USFDA approval for Gabapentin
05 Mar 2024 //
BUSINESS STD
Strides reports strong Q3FY24 Revenue and EBITDA
30 Jan 2024 //
BSEINDIA
Strides Pharma Science to invest in AMP-6, AMP-8
03 Jan 2024 //
INDIAN PHARMA POST
Strides Science extends guarantee to Trinity Pharma Proprietary’s borrowing
21 Dec 2023 //
INDIAN PHARMA POST
Strides launches Icosapent Ethyl Acid Soft Gel capsules in
02 Dec 2023 //
INDIAN PHARMA POST
Strides Pharma to sell its Singapore manufacturing facility for $15 million
27 Oct 2023 //
ENDPTS
Strides Pharma to spin off contract development unit
25 Sep 2023 //
ECONOMIC TIMES
Strides sells arm`s manufacturing unit to Syngene International for Rs 702 crore
05 Jul 2023 //
ECONOMIC TIMES
Strides and Orbicular enter into a strategic partnership for nasal sprays
04 May 2023 //
INDIANPHARMAPOST
Strides Pharma Global receives AUD 94 mn for sale of Australia`s operations
23 Dec 2022 //
INDIANPHARMAPOST
Strides Pharma subsidiary gets USFDA nod for drug product capabilities
01 Sep 2022 //
CNBC TV18
Strides Pharma gets USFDA nod for anti-inflammatory drug
18 Aug 2022 //
BUSINESS-STANDARD
Strides Pharma Arm Gets EU-GMP Certification For Two Facilities
16 Jun 2022 //
OUTLOOKINDIA
Strides gets USFDA nod for generic drug with 180-day exclusivity
11 Jun 2022 //
ET HEALTH
Strides Pharma Gets USFDA Nod for Colchicine Tablets
12 Mar 2022 //
MEDICAL DIALOGUES
Strides Pharma arm gets USFDA nod to market Amantadine HCl Softgel
20 Feb 2022 //
ECONOMIC TIMES
Strides Pharma Science to acquire Endo’s manufacturing facility in US
06 Aug 2021 //
EXPRESS PHARMA
Strides Pharma Science to acquire Endo`s manufacturing facility in US
05 Aug 2021 //
ECONOMIC TIMES
Strides Pharma arm receives USFDA nod for potassium chloride oral solution
15 Mar 2021 //
ECONOMICTIMES
Strides receives US FDA approval for potassium chloride for oral solution
15 Mar 2021 //
PHARMABIZ
Strides Pharma Science arm gets American drug regulator`s nod for pain
23 Feb 2021 //
ECONOMICTIMES
Strides Pharma to spin off biopharma biz, start vaccines with global player
04 Feb 2021 //
BUSINESS-STANDARD
